Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Dismantling Trial of Exposure Therapy for Reactivity to Symptoms

NCT07757854 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT07757854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07757854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Dismantling Trial of Exposure Therapy for Reactivity to Symptoms
Lead sponsor
Region Stockholm
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
December 31, 2031
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bodily distress disorder, psychological factors affecting other medical conditions, somatic symptom and related disorders